Jingwu Zhang Zang

Direktor/Vorstandsmitglied bei HH&L ACQUISITION CO.

Vermögen: 7 Mio $ am 30.04.2024

68 Jahre

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Jingwu Zhang Zang

Unternehmen	Position	Beginn	Ende
HH&L ACQUISITION CO.	Direktor/Vorstandsmitglied	04.02.2021	-
HH&L ACQUISITION CO.	Independent Dir/Board Member	04.02.2021	-
I-MAB Biopharma Co., Ltd. I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China.	Gründer	01.06.2016	-
	Vorsitzender	24.08.2016	-
	Vorstandsvorsitzender	24.08.2016	-

Unternehmen	Position	Beginn	Ende
I-MAB	Direktor/Vorstandsmitglied	01.10.2019	01.03.2021
	Vorstandsvorsitzender	01.01.2022	30.09.2022
	Vorsitzender	01.03.2021	10.02.2024
	Gründer	30.06.2016	10.02.2024
SIMCERE PHARMACEUTICAL GROUP LIMITED	Präsident	01.09.2013	01.04.2016
BioSciKin Co., Ltd. BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2013	01.04.2016
	Präsident	01.09.2013	01.04.2016
Glaxosmithkline China Ltd.	Technik-/Wissenschafts-/F&E-Leiter	01.04.2007	01.06.2013
Shanghai Jiao Tong University School of Medicine	Corporate Officer/Principal	01.06.2002	01.04.2007
Institut Pasteur de Shanghai Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China.	Direktor/Vorstandsmitglied	01.10.2004	01.09.2006
The Institute of Health Sciences	Direktor/Vorstandsmitglied	-	-
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-	-
░░░░░░ ░░░░░░░ ░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-	-

Shanghai Jiao Tong University	Doctorate Degree
Vrije Universiteit Brussel	Doctorate Degree

International

Operativ

Director/Board Member	4
Corporate Officer/Principal	3
President	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
SIMCERE PHARMACEUTICAL GROUP LIMITED	Health Technology
I-MAB	Health Technology

Private Unternehmen	7
Opexa Pharmaceuticals, Inc.	Health Technology
Institut Pasteur de Shanghai Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China.	Commercial Services
Glaxosmithkline China Ltd.
I-MAB Biopharma Co., Ltd. I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China.	Health Technology
BioSciKin Co., Ltd. BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China.	Health Technology
The Institute of Health Sciences
HH&L Acquisition Co. HH&L Acquisition Co. Financial ConglomeratesFinance HH&L Acquisition Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on September 4, 2020 and is headquartered in Hong Kong.	Finance